Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Relo Group, Apr-Dec (Cumulative 3Q) Net Income Decreases by 61%
8876 Relo Group, Inc. 【IFRS】
Earnings ReportRelo Group, Inc. <8876> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 12th (15:30). The consolidated net income for the cumulative third quarter of the fiscal year ending March 2026 (April to December) significantly dropped 60.8% from the same period last year to 14.6 billion yen. Progress toward the full-year plan of 21.0 billion yen was 69.6%, also falling below the five-year average of 75.4%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income for the January to March period (4Q) is expected to grow 5.7% from the same period last year, reaching 6.38 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated net income grew 3.4% from the same period last year, reaching 4.45 billion yen. The operating profit margin rose from 17.4% in the same period last year to 18.1%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 94,429 | 17,985 | 18,557 | 12,638 | 82.7 | ー | Feb 8, 2024 | IFRS |
| Apr - Dec, 2024 | 104,819 | 21,714 | 43,992 | 37,279 | 246.2 | 83.2 | Feb 13, 2025 | IFRS |
| Apr - Dec, 2025 | 108,968 | 21,360 | 21,361 | 14,620 | 97.1 | 68.5 | Feb 12, 2026 | IFRS |
| YoY | +4.0% | -1.6% | -51.4% | -60.8% | -60.5% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 72,835 | 14,773 | 14,964 | 10,345 | 68.5 | 42 | May 8, 2025 | IFRS |
| Oct - Mar, 2025 Guidance | 77,071 | 16,548 | 16,282 | 10,834 | 71.7 | 49 | Nov 13, 2025 | IFRS |
| YoY | +5.8% | +12.0% | +8.8% | +4.7% | +4.6% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 132,580 | 27,611 | -19,404 | -27,807 | -181.9 | 37 | May 9, 2024 | IFRS |
| Mar, 2025 | 142,908 | 30,437 | 52,863 | 43,317 | 286.9 | 42 | May 8, 2025 | IFRS |
| Mar, 2026 Guidance | 150,000 | 31,400 | 31,200 | 21,000 | 138.9 | 49 | May 8, 2025 | IFRS |
| YoY | +5.0% | +3.2% | -41.0% | -51.5% | -51.6% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 34,746 | 6,050 | 6,093 | 4,307 | 28.4 | 17.4 | Feb 13, 2025 | IFRS |
| Jan - Mar, 2025 | 38,089 | 8,723 | 8,871 | 6,038 | 40.0 | 22.9 | May 8, 2025 | IFRS |
| Apr - Jun, 2025 | 35,745 | 6,415 | 6,420 | 4,414 | 29.5 | 17.9 | Aug 7, 2025 | IFRS |
| Jul - Sep, 2025 | 37,184 | 8,437 | 8,498 | 5,752 | 38.3 | 22.7 | Nov 13, 2025 | IFRS |
| Oct - Dec, 2025 | 36,039 | 6,508 | 6,443 | 4,454 | 29.6 | 18.1 | Feb 12, 2026 | IFRS |
| YoY | +3.7% | +7.6% | +5.7% | +3.4% | +4.0% |
Related Articles
CRI Middleware, Oct-Dec (1Q) Ordinary Profit Decreases by 74%
ExaWizards, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Increases by 237 times
Human Metabolome Tech, First Half Ordinary Profit Decreases by 50%
NETSTARS, 60% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
MEIWA INDUSTRY, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 10%, Oct-Dec Ordinary Profit Decreases by 83%
PIOLAX, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 25%
TBK, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 30%
Shikino High-Tech, Ordinary Profit Forecast for the Fiscal Year Revised Downward to a Loss
StemCell Institute, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 38%, Oct-Dec Ordinary Profit Decreases by 11%
SBI ARUHI, Apr-Dec (Cumulative 3Q) Net Income Increases by 10%, Exceeds Full-Year Plan